• No notifications yet.
  • Sign Out
logo image
  • logo image
Registered User? Login

The community gives you the chance to connect and engage with delegates attending this event.

Access to the community is available for registered attendees only. 

If you have already registered, please join using the link below. To register for the event please follow the 'Register for free' button and summit your details. Please contact ftlive@ft.com with any questions.

Forgot Password?
Sign Up
loader image
New User? Sign Up

The community gives you the chance to connect and engage with delegates attending this event.

Access to the community is available for registered attendees only. 

If you have already registered, please join using the link below. To register for the event please follow the 'Register for free' button and summit your details. Please contact ftlive@ft.com with any questions.

Forgot Password?
Login
loader image

    Why Attend?

    Full Overview

    These are challenging times for CFOs of healthcare and life sciences companies in Europe and the US. Whether it’s a pharma company facing delayed clinical trials, or a provider/payer facing loss of income from elective procedures and potential premium shortfalls as labour cuts begin to make an impact, the pandemic has had a varied impact on organisations. However, common across companies has been the disruptive effect of COVID-19 on supply chains and workforce management. It has upended operating models and necessitated new, more virtual ways of working. Meanwhile, beyond the immediate horizon, transition to value-based care and the rise of innovative payment models are back under the spotlight, as the impact of the pandemic recedes.

    Getting to grips with the aforementioned challenges and outperforming competition will require a multi-pronged approach. Aggressive costs controls, and Merger and Acquisition (M&A) will be crucial, as companies look to offset revenue losses and capitalise on new growth opportunities. Undoubtedly, digital adoption is going to be a key enabler. Harnessing technologies such as Artificial Intelligence (AI) and Advanced Data Analytics, for instance, can provide visibility across all CFO operations, highlighting the potential for efficiency gains, better enabling M&A, as well as leading to more secure and resilient supply chains. A digitally enabled workforce, and smarter decision-making across the value chain and regulatory compliance are among the other potential advantages. 

    The Financial Times, in partnership with WNS, was honoured to host this exclusive virtual webinar for senior financial decision makers of healthcare and life sciences companies from across Europe and the US. Hear from an esteemed panel of corporate leaders as they share their experience of navigating the COVID-19 crisis, and discuss how they are positioning their organisations for growth and agility in a post-pandemic era.

    view on-demand

    Why Attend?

    Understand

    The big picture, not just the individual strands of the business you work in

    Connect

    And build relationships with some of the biggest names in your industry

    Discover

    New approaches and strategies to help win market share

    Premier Digital Events supported by the world's best journalism

    Using leading digital technology, we have now taken our content, global audience reach and engagement to a new level through a series of unmissable virtual events. Our compelling events are chaired by respected FT journalists, feature the most senior and thought-provoking decision-makers in business, finance and politics, all accessible from your office or home.

    View all events

    © Financial Times Live

    FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice

                    

    LEGAL

    FT Live Website Terms of Use
    Slavery Statement & Policies
    Contact us



    FT Live Delegate Terms & Conditions
    Privacy policy
    Cookie policy

Contact the organizer
Contact the organizer